Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

5 most popular Pharma R&D blog posts of 2016

Posted on February 1st, 2017 by in Pharma R&D

The top blogs in this category reflect just how much politics and current events can mean to the health of the pharmaceutical industry, Continue reading “5 most popular Pharma R&D blog posts of 2016” »

The Costs of Irreproducible Biomedical Research

Posted on November 28th, 2016 by in Pharma R&D

money-case-163495_640

Issues with reproducibility plague basic biomedical research. In a June 2015 study published in PLoS Biology, the authors suggested that U.S. researchers spend $28 billion a year on research that is irreproducible. Continue reading “The Costs of Irreproducible Biomedical Research” »

Collaborating to Treat Rare Diseases

Posted on November 16th, 2016 by in Pharma R&D

There are about 7,000 diseases out there that are considered “rare,” but they actually affect hundreds of millions of people worldwide – nearly half of whom are children. Continue reading “Collaborating to Treat Rare Diseases” »

  1. 1
  2. 2
  3. 3